Skip to main content
. Author manuscript; available in PMC: 2021 Mar 2.
Published in final edited form as: Chembiochem. 2019 Nov 7;21(5):712–722. doi: 10.1002/cbic.201900434

Figure 7.

Figure 7.

A) Immunoblots of KMS11, KMS12, HEK293, and SW1271 showing UCHL1 expression. B) Compound 1 displays a dose-dependent effect on the viability of SW1271 cells (CC50 = 138.9 nM). C) Compound 1 decreases the rate of proliferation for both KMS11 and KMS12 cells at 25 μM.